EVIDENCE BASE AND REGULATORY PATHWAYS

Monday, March 10, 2025

3:48 PM – 4:44 PM ET

Moderator(s)

Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Panel Discussant(s)

Chris G. Bruce, MBChB

Interventional cardiologist
National Heart, Lung and Blood Institute
Bethesda, Maryland, United States

Disclosure(s): Transmural Sesame LLC: Consulting Fees (e.g., advisory boards) (Terminated, July 1, 2024)
Rim Halaby, MD

Interventional Cardiologist/Staff Clinician
National Institutes of Health/National Heart, Lung, and Blood Institute

Disclosure(s): No financial relationships to disclose
Robert J. Lederman, MD

Senior Investigator, Chief, Laboratory of Cardiovascular Intervention
National Institutes of Health/National Heart, Lung, and Blood Institute
Bethesda, Maryland, United States

Disclosure(s): No financial relationships to disclose
Paul D. Mahoney, MD, FACC, FSCAI

Chief, Interventional Cardiology, Director, Structural Heart Program
ECU Health
Greenville, North Carolina, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Clinical Proctor (Ongoing), Consultant (Ongoing)

Disclosure(s):

Toby Rogers, MD, PhD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Transmural Systems, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)

Chris G. Bruce, MBChB: Transmural Sesame LLC: Consulting Fees (e.g., advisory boards) (Terminated, July 1, 2024)

Rim Halaby, MD: No financial relationships to disclose

Azeem Latib, MD: Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)

Robert J. Lederman, MD: No financial relationships to disclose

Paul D. Mahoney, MD, FACC, FSCAI: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Clinical Proctor (Ongoing), Consultant (Ongoing)